期刊文献+

恶性肿瘤相关静脉血栓栓塞症研究进展 被引量:7

下载PDF
导出
摘要 恶性肿瘤是静脉血栓栓塞症(venous thromboembolism,VTE)的一个重要病因,其发病率与肿瘤部位、分期、治疗方法以及患者地区、年龄和种族有关。恶性肿瘤通过多种机制破坏了机体的凝血、抗凝、纤溶系统的平衡,诱导机体的高凝状态和血栓前变化,并促进癌肿本身的生长和转移,形成一个恶性循环。对于确诊VTE的恶性肿瘤患者,长期抗凝治疗尤为重要,以低分子肝素作为首选抗凝药物。VTE的发生对于恶性肿瘤患者的预后指标有不良影响,而抗凝治疗也有可能改善恶性肿瘤患者的预后。选择最有效抗凝药物和最大获益肿瘤人群,是需要进一步研究的内容。
作者 崔志刚 孔棣
出处 《中国中西医结合外科杂志》 CAS 2013年第1期97-99,共3页 Chinese Journal of Surgery of Integrated Traditional and Western Medicine
  • 相关文献

参考文献26

  • 1Lyman GH. Venous thromboembolism in the patient with cancer:focus on burden of disease and benefits of thromboprophylaxis [J].Cancer,2011,117(7):1334-1349. 被引量:1
  • 2Khorana AA, Francis CW, Culakova E, et al.Thromboembolism inhospitalized neutropenic cancer patients [J].J Clin Oncol, 2006,24(3):484-490. 被引量:1
  • 3M. Mandala、,A. Falanga, F.Roila. Venous thromboembolism incancer patients: ESMO Clinical Practice Guidelines for the man-agement [J].Ann Oncol, 2010, 21 (5): 274-276. 被引量:1
  • 4Cronin-Fenton DP, S0ndergaard F, Pedersen LA, et al. Hospitalisa-tion for venous thromboembolism iri cancer patients and the gener-al population: a population-based cohort study in Denmark,1997-2006 [J].Br J Cancer, 2010, 103(7):947-953. 被引量:1
  • 5Behranwala KA, Williamson RC. Cancer-associated venous throm-bosis in the surgical setting [J].Ann Surg, 2009,249⑶:366-375. 被引量:1
  • 6Hanna N, Bikov KA, McNally D, et al. Impact of Venous Thrombo-embolism on Mortality of Elderly Medicare Patients with Stage IIIColon Cancer [J].Oncologist, 2012, 17(9):1191-1197. 被引量:1
  • 7Khorana AA, Rao MV. Approaches to risk-stratifying cancer pa-tients for venous thromboembolism [J].Thromb Res, 2007,120(2):41-50. 被引量:1
  • 8Khorana AA, Connolly GC. Assessing risk of venous thromboembo-lism in the patient with cancer [J].Clin Oncol, 2009,27(29):4839-4847. 被引量:1
  • 9Mandai6 M, Bami S, Prins M, et al. Acquired and inherited riskfactors for developing venous thromboembolism in cancer patientsreceiving adjuvant chemotherapy: a prospective trial [J].Ann On-col, 2010,21(4):871-876. 被引量:1
  • 10SchmidtM, Horvath-Puho E,Thomsen RW, et al. Acute infec-tions and venous thromboembolism [J].J Intern Med, 2012,271(6):608-618. 被引量:1

同被引文献87

  • 1王蓓,曹素艳,王雁,许锋.老年肿瘤患者合并静脉血栓栓塞症的临床调查[J].中华老年医学杂志,2007,26(6):426-428. 被引量:10
  • 2魏瑶,于世英.NCCN静脉血栓栓塞性疾病临床指引(2006.2版)[J].循证医学,2007,7(5):295-312. 被引量:5
  • 3Delluc A,Rousseau A,Delluc C,et al.Venous thromboembolism in patients with pancreatic cancer:implications of circulating tissue factor[J].Blood Coagul Fibrinolysis,2011,22:295-300. 被引量:1
  • 4Bobek V,Kovar KJ.Antitumor and antimetastatic effect of warfarin and heparins[J].Biomed Pharmacother,2004,58:213-219. 被引量:1
  • 5Khorana AA,Connolly GC.Assessing risk of venous thromboembolism in the patient with cancer[J].Clin Oncol,2009,27:4839-4847. 被引量:1
  • 6Schmidt M,Horvath-Puho E,Thomsen RW,et al.Acute infections and venous thromboembolism[J].J Intern Med,2012,271:608-618. 被引量:1
  • 7Caine GJ,Lip GY,Zanetto U,et al.A comparison of plasma versus histologic indices of angiogenic markers in breast cancer[J].Appl Immunohistochem Mol Morphol,2007,15:382-388. 被引量:1
  • 8Verso M,Agnelli G,Bertoglio S,et al.Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter:a double-blind,placebo-controlled,randomized study in cancer patients[J].J Clin Oncol,2005,23:4057-4062. 被引量:1
  • 9Murchison JT,Wylie L,Stockton DL.Excess risk of cancer in patients with primary venous thromboembolism:a national,population-based cohort study[J].Br J Cancer,2004,91:92-95. 被引量:1
  • 10Kearon C,Akl EA,Comerota AJ,et al.Antithrombotic therapy for VTE disease:Antithrombotic Therapy and Prevention of Thrombosis,9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J].Chest,2012,141:419-494. 被引量:1

引证文献7

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部